NCT01539265View on ClinicalTrials.gov

A Dose-finding Study of Silodosin in Patients With Urinary Calculi

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

Not specified

Conditions
Urinary Calculus
Interventions
DRUG

silodosin

DRUG

silodosin

DRUG

placebo

Trial Locations (1)

Unknown

Japan, Tokyo and Other Japanese City

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT01539265 - A Dose-finding Study of Silodosin in Patients With Urinary Calculi | Biotech Hunter | Biotech Hunter